China portfolio company RedPine raises Series B
Our China portfolio company RedPine has recently completed a Series B financing round.

The round is led by well-known investment institutions in China, with participation from Eight Roads and other existing investors.

The company will use the funds to further build its product pipeline, strengthen its clinical capabilities, and drive market education for its existing products.

Founded in 2015 and headquartered in Guangzhou, RedPine is a disposable endoscope maker that is named as a National High Technology Enterprise by the government. The company has a product portfolio covering urology, gynecology, otolaryngology, respiratory, and general surgery among others nationwide. As of now, RedPine has applied for more than 50 patents and granted more than 30, bringing the company on par with global medical device giants in this technology field.

Med tech is one of the key focused areas for Eight Roads’ healthcare team in China. Inspired by the leadership and expertise of the RedPine team, we led the company’s Series A financing in 2020.